Chr Hansen

Chr. Hansen and Nestlé settle HMO patent litigation

Chr. Hansen and Nestlé settle HMO patent litigation

By Will Chu

Chr. Hansen and Nestlé have settled a legal dispute involving alleged infringements on Human Milk Oligosaccharide (HMO) patents arising from October 2020’s acquisition of Jennewein Biotechnologie.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers